Comparative efficacy of three doses of intravenous immunoglobulin in the treatment of Myasthenia Gravis (MG) as a prelude to comparing efficacy of low dose intravenous and subcutaneous immunoblobulin in MG
|Effective start/end date||3/1/06 → 12/31/12|
- Grifols Therapeutics, Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.